Opsens (TSE:OPS) Coverage Initiated at Stifel Nicolaus

Equities research analysts at Stifel Nicolaus initiated coverage on shares of Opsens (TSE:OPSGet Rating) in a report released on Wednesday, TipRanks reports. The firm set a “buy” rating and a C$3.35 price target on the stock. Stifel Nicolaus’ price objective suggests a potential upside of 61.84% from the stock’s previous close.

OPS has been the topic of a number of other research reports. Raymond James raised their target price on shares of Opsens to C$6.00 and gave the company a “strong-buy” rating in a research report on Tuesday, February 22nd. Royal Bank of Canada raised their target price on shares of Opsens to C$4.00 and gave the company an “outperform” rating in a research report on Tuesday, January 4th.

Shares of OPS opened at C$2.07 on Wednesday. Opsens has a 1-year low of C$1.57 and a 1-year high of C$3.74. The company has a 50-day moving average of C$1.94 and a 200 day moving average of C$2.60. The firm has a market capitalization of C$223.52 million and a price-to-earnings ratio of -50.49. The company has a debt-to-equity ratio of 14.69, a current ratio of 8.52 and a quick ratio of 7.25.

Opsens (TSE:OPSGet Rating) last announced its quarterly earnings data on Thursday, January 13th. The company reported C($0.02) earnings per share for the quarter, missing analysts’ consensus estimates of C($0.01) by C($0.01). The company had revenue of C$8.10 million for the quarter, compared to the consensus estimate of C$10.00 million. On average, equities analysts anticipate that Opsens will post 0.04 earnings per share for the current fiscal year.

About Opsens (Get Rating)

Opsens Inc develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology.

Further Reading

Receive News & Ratings for Opsens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opsens and related companies with MarketBeat.com's FREE daily email newsletter.